New York S01795 allows pharmacists to substitute alternate epinephrine auto-injectors for brand name ones under certain conditions.
New York S01795 amends the education law to allow pharmacists to substitute an alternate epinephrine auto-injector for a brand name one, provided the alternate has the same active ingredients, dosage form, and strength. This substitution can occur even if the alternate is not on the latest list of interchangeable drug products. The substitution is permissible if the prescriber does not specify that the brand name must be dispensed, the alternate is cheaper, the pharmacist informs the patient about the availability of the alternate and obtains consent, and the pharmacist counsels the patient.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.